Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/21/1997 | US5679355 Vaccines containing non-ionic surfactant vesicles |
10/21/1997 | US5679337 Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient |
10/21/1997 | US5679328 Improved rheological properties |
10/21/1997 | US5679325 Lidocaine aerosol anaesthetic |
10/21/1997 | US5679324 Containing ethoxylated and/or propoxylated lanolin oil surfactant, fluorocarbon and/or hydrocarbon gas propellant, fragrance, thickener, cosmetic vehicle |
10/21/1997 | CA1339502C Anti-cancer activity potentiator |
10/16/1997 | WO1997038480A1 Electrostatic chucks |
10/16/1997 | WO1997038010A2 Fusogenic liposomes |
10/16/1997 | WO1997037803A1 Chucks and methods for positioning multiple objects on a substrate |
10/16/1997 | WO1997037689A2 Denaturants for sympathomimetic amine salts |
10/16/1997 | WO1997037668A1 Use of macrolide antibiotics for nonsurgical female sterilization and endometrial ablation |
10/16/1997 | WO1997037659A1 Transdermal delivery device for azapirone compounds |
10/16/1997 | WO1997037653A1 Injection formulations of avermectins and milbemycins based on castor oil |
10/16/1997 | WO1997037650A1 Remedies for retinal diseases |
10/16/1997 | WO1997037643A1 Process and product for the treatment of arthritis |
10/16/1997 | WO1997037642A1 Estradiol and progesterone-based medicament |
10/16/1997 | WO1997037641A1 Oral coated active drugs |
10/16/1997 | WO1997037640A2 Uniform drug delivery therapy |
10/16/1997 | WO1997037639A1 Controlled-release pharmaceutical tablet containing a carrier based on cross-linked amylose and hydroxypropylmethylcellulose |
10/16/1997 | WO1997037638A2 Process for producing small doses of fluid and/or directly compressible powder systems |
10/16/1997 | WO1997037637A1 Liposome-based topical vitamin d formulation |
10/16/1997 | WO1997037636A1 Therapeutic and preventive method against harmful microbes |
10/16/1997 | WO1997037629A1 Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
10/16/1997 | WO1997030714A3 Topical pharmaceutical composition containing heparin |
10/16/1997 | WO1997024125A3 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
10/16/1997 | DE19613972A1 Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl Injection formulations of avermectins and milbemycins based on castor oil |
10/16/1997 | CA2251330A1 Chucks and methods for positioning multiple objects on a substrate |
10/16/1997 | CA2251022A1 Oral coated active drugs |
10/15/1997 | EP0800860A1 Process and device for the agglomeration of products sensitive to hydrolysis using steam |
10/15/1997 | EP0800830A2 Method of in vivo delivery of functioning foreign genes |
10/15/1997 | EP0800828A1 Transmucosal preparation |
10/15/1997 | EP0800825A1 Stable aqueous solutes containing carotenoids and vitamins |
10/15/1997 | EP0800824A1 Stable carotenoid emulsions for parenteral administration |
10/15/1997 | EP0800822A2 Method for preparing closed vesicles by rehydration of dehydrated vesicles |
10/15/1997 | EP0800821A2 Compositions comprising benzoyl peroxide and diethylene glycol monoethyl ether; method for their preparation |
10/15/1997 | EP0800392A1 Pharmaceutical preparations containing nifedipine and process for producing it |
10/15/1997 | EP0800386A1 Transdermal system for the simultaneous delivery of a number of active principles |
10/15/1997 | EP0800385A1 Oral sustained-release preparation |
10/15/1997 | EP0800384A1 Pharmaceutical tablet formulations for direct compression |
10/15/1997 | EP0800383A1 Proliposome powders for inhalation |
10/15/1997 | EP0800364A1 Transdermal administration of apomorphine |
10/15/1997 | EP0744992B1 Process for preparing particles or powders |
10/15/1997 | EP0737052A4 Transdermal drug delivery system |
10/15/1997 | EP0654065B1 Package material and transdermal drug delivery device |
10/15/1997 | EP0546036B1 Vaccines |
10/15/1997 | CN2264589Y Umbilicus application for children |
10/15/1997 | CN1162265A Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability and process for producing them |
10/15/1997 | CN1162263A Cisapride extended release oral compositions |
10/15/1997 | CN1162262A Antiinflammatory agent for external use |
10/15/1997 | CN1162260A Medicinal patches for percutaneous administration |
10/15/1997 | CN1162259A 药物组合物 The pharmaceutical composition of |
10/15/1997 | CN1161853A Consciousness-restoring and body-building capsule |
10/15/1997 | CN1161846A Ointment for subsidence of swelling and relieving pain |
10/15/1997 | CN1161843A Chinese medicine of spraying-applying dual purpose mainly for treating burn and scald and preparation method thereof |
10/15/1997 | CN1161790A Edible micro-capsule and food containing same |
10/14/1997 | US5677355 Continuous open-cell polymeric foams containing living cells |
10/14/1997 | US5677346 Treating urinary incontinence using (S)-desethyloxybutynin |
10/14/1997 | US5677341 Mixture with lipid, nonionic surfactants and cholesterol |
10/14/1997 | US5677337 Adminstering as anticarcinogenic agents |
10/14/1997 | US5677324 Benzopyranes as potassium channel openers |
10/14/1997 | US5677284 Charged collagen particle-based delivery matrix |
10/14/1997 | US5677176 Animal derived cell with antigenic protein introduced therein |
10/14/1997 | US5677148 Genetic engineering |
10/14/1997 | US5676976 Precipitating carbonated amorphous calcium phosphate from aqueous solution comprising calcium, phosphate and carbonate ions, heating to remove atleast a portion of residual water and a portion of carbonate ion to retain amorphous character |
10/14/1997 | US5676972 Active ingredient dispersed in matrix comprising blend of polyoxyalkylene glycol, polyhydroxyalkyl acrylate, low molecular weight copolymer having both hydrophilic and hydrophobic groups |
10/14/1997 | US5676971 Agents for inhibiting adsorption of proteins on the liposome surface |
10/14/1997 | US5676970 Anti-inflammatory analgesic plaster |
10/14/1997 | US5676969 Monolithic carrier layer of active ingredient melt-blended with thermoplastic matrix polymer capable of controlled release, impermeable backing layer, pressure sensitive adhesive for affixing to skin or mucosa |
10/14/1997 | US5676968 Containing penetration promoter, active material and adhesive |
10/14/1997 | US5676965 Use of polydeoxyribonucleotides in diabetic neuropathies |
10/14/1997 | US5676962 Injectable microfoam containing a sclerosing agent |
10/14/1997 | US5676954 Administering by injection a nucleic acid-cationic liposome complex capable of functionally expressing the gene to the mammal at a site whereby target organ is the first organ having a capillary bed proximal to site of administeration |
10/14/1997 | US5676943 Nerve growth factor |
10/14/1997 | US5676931 Aerosol drug formulations for use with non CFC propellants |
10/14/1997 | US5676930 Containing a medicine, a fluorohydrocarbon propellant, ethanol and either ascorbic or citric acid as stabilizer |
10/14/1997 | US5676929 Canister containing aerosol formulations containing P134a and particulate medicaments |
10/14/1997 | CA2130341C Compositions of clindamycin and benzoyl peroxide for acne treatment |
10/13/1997 | CA2179341A1 Methods for isolating, enriching and increasing the maturation of cells |
10/12/1997 | CA2202425A1 A novel anti-spasmodic and antiinflammatory composition and a process for the manufacture thereof |
10/11/1997 | CA2173818A1 Time-released pharmaceutical compound containing a cured amylose-based support and hydroxypropylmethylcellulose |
10/09/1997 | WO1997037030A1 Method of screening dna-binding protein, plasmid to be used therefor, and dna-binding protein |
10/09/1997 | WO1997036949A1 Improved preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using the same |
10/09/1997 | WO1997036643A1 Compressible vaginal insert and device for treating urogenital disorders |
10/09/1997 | WO1997036611A1 Cyclosporin emulsions |
10/09/1997 | WO1997036610A1 Cyclosporin-containing pharmaceutical composition |
10/09/1997 | WO1997036598A1 Use of aminoalkylcarboxylic derivatives |
10/09/1997 | WO1997036594A1 Vitamin b2-containing medicines |
10/09/1997 | WO1997036578A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy |
10/09/1997 | WO1997036577A1 Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability |
10/09/1997 | WO1997036576A1 Preparation method of emulsion for chemoembolization |
10/09/1997 | WO1997036575A1 Novel laxative compositions and method for making same |
10/09/1997 | WO1997036574A1 Process and device for inhalation of particulate medicaments |
10/09/1997 | WO1997036568A2 Herbal treatments for improving skin appearance |
10/09/1997 | WO1997036555A1 Material for buffered resorbable internal fixation devices and method for making same |
10/09/1997 | WO1997036497A2 Cocoa extract compounds and methods for making and using the same |
10/09/1997 | WO1997036495A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
10/09/1997 | WO1997036485A1 Insecticidal combination effective against fleas on mammals, particularly cats and dogs |
10/09/1997 | WO1997036480A1 Compounds and compositions for delivering active agents |
10/09/1997 | WO1997030699A3 Dosage form of ibuprofen |
10/09/1997 | WO1997026864A3 Methods and compositions for enhancing the bioadhesive properties of polymers |